nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—thyroid cancer	0.551	0.836	CbGaD
Acetylsalicylic acid—PTGS2—thyroid cancer	0.108	0.164	CbGaD
Acetylsalicylic acid—ALB—Vandetanib—thyroid cancer	0.0397	0.372	CbGbCtD
Acetylsalicylic acid—CYP2C8—Sorafenib—thyroid cancer	0.0185	0.173	CbGbCtD
Acetylsalicylic acid—CYP2C19—Sorafenib—thyroid cancer	0.0155	0.145	CbGbCtD
Acetylsalicylic acid—TP53—larynx—thyroid cancer	0.0139	0.199	CbGeAlD
Acetylsalicylic acid—CYP2C9—Sorafenib—thyroid cancer	0.0129	0.121	CbGbCtD
Acetylsalicylic acid—ABCB1—Sorafenib—thyroid cancer	0.0125	0.117	CbGbCtD
Acetylsalicylic acid—ABCB1—Doxorubicin—thyroid cancer	0.0076	0.0712	CbGbCtD
Acetylsalicylic acid—TP53—neck—thyroid cancer	0.00367	0.0526	CbGeAlD
Acetylsalicylic acid—NFKBIA—neck—thyroid cancer	0.00361	0.0518	CbGeAlD
Acetylsalicylic acid—HSPA5—neck—thyroid cancer	0.00354	0.0507	CbGeAlD
Acetylsalicylic acid—TP53—saliva-secreting gland—thyroid cancer	0.00286	0.0411	CbGeAlD
Acetylsalicylic acid—NFKBIA—saliva-secreting gland—thyroid cancer	0.00282	0.0404	CbGeAlD
Acetylsalicylic acid—HSPA5—saliva-secreting gland—thyroid cancer	0.00276	0.0396	CbGeAlD
Acetylsalicylic acid—RPS6KA3—saliva-secreting gland—thyroid cancer	0.00235	0.0337	CbGeAlD
Acetylsalicylic acid—TP53—trachea—thyroid cancer	0.00221	0.0317	CbGeAlD
Acetylsalicylic acid—NFKBIA—trachea—thyroid cancer	0.00217	0.0312	CbGeAlD
Acetylsalicylic acid—HSPA5—trachea—thyroid cancer	0.00213	0.0305	CbGeAlD
Acetylsalicylic acid—RPS6KA3—trachea—thyroid cancer	0.00181	0.026	CbGeAlD
Acetylsalicylic acid—TP53—thyroid gland—thyroid cancer	0.00175	0.0251	CbGeAlD
Acetylsalicylic acid—NFKBIA—thyroid gland—thyroid cancer	0.00172	0.0246	CbGeAlD
Acetylsalicylic acid—HSPA5—thyroid gland—thyroid cancer	0.00168	0.0241	CbGeAlD
Acetylsalicylic acid—TP53—head—thyroid cancer	0.00155	0.0222	CbGeAlD
Acetylsalicylic acid—NFKBIA—head—thyroid cancer	0.00153	0.0219	CbGeAlD
Acetylsalicylic acid—HSPA5—head—thyroid cancer	0.00149	0.0214	CbGeAlD
Acetylsalicylic acid—EDNRA—trachea—thyroid cancer	0.00147	0.0211	CbGeAlD
Acetylsalicylic acid—RPS6KA3—thyroid gland—thyroid cancer	0.00143	0.0206	CbGeAlD
Acetylsalicylic acid—RPS6KA3—head—thyroid cancer	0.00127	0.0182	CbGeAlD
Acetylsalicylic acid—Respiratory failure—Vandetanib—thyroid cancer	0.00124	0.0352	CcSEcCtD
Acetylsalicylic acid—EDNRA—thyroid gland—thyroid cancer	0.00117	0.0167	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—thyroid cancer	0.00109	0.0156	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—thyroid cancer	0.00107	0.0153	CbGeAlD
Acetylsalicylic acid—IKBKB—thyroid gland—thyroid cancer	0.00106	0.0152	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—thyroid cancer	0.00105	0.015	CbGeAlD
Acetylsalicylic acid—IKBKB—head—thyroid cancer	0.00094	0.0135	CbGeAlD
Acetylsalicylic acid—Hypoglycaemia—Vandetanib—thyroid cancer	0.000905	0.0257	CcSEcCtD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—thyroid cancer	0.000899	0.338	CrCbGaD
Acetylsalicylic acid—RPS6KA3—lymph node—thyroid cancer	0.000891	0.0128	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.000883	0.0251	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Vandetanib—thyroid cancer	0.000804	0.0228	CcSEcCtD
Acetylsalicylic acid—Influenza—Vandetanib—thyroid cancer	0.000764	0.0217	CcSEcCtD
Acetylsalicylic acid—EDNRA—lymph node—thyroid cancer	0.000725	0.0104	CbGeAlD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—thyroid cancer	0.000682	0.173	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—thyroid cancer	0.000682	0.173	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—thyroid cancer	0.000682	0.173	CbGdCrCtD
Acetylsalicylic acid—IKBKB—lymph node—thyroid cancer	0.000658	0.00943	CbGeAlD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—thyroid cancer	0.000631	0.16	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—thyroid cancer	0.000631	0.16	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—thyroid cancer	0.000631	0.16	CbGdCrCtD
Acetylsalicylic acid—Kidney function abnormal—Epirubicin—thyroid cancer	0.000628	0.0178	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Vandetanib—thyroid cancer	0.000614	0.0174	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Vandetanib—thyroid cancer	0.000611	0.0174	CcSEcCtD
Acetylsalicylic acid—Kidney function abnormal—Doxorubicin—thyroid cancer	0.000581	0.0165	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Sorafenib—thyroid cancer	0.000542	0.0154	CcSEcCtD
Acetylsalicylic acid—Salsalate—PTGS2—thyroid cancer	0.000524	0.197	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—thyroid cancer	0.000516	0.194	CrCbGaD
Acetylsalicylic acid—Eruption—Epirubicin—thyroid cancer	0.000493	0.014	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Vandetanib—thyroid cancer	0.000468	0.0133	CcSEcCtD
Acetylsalicylic acid—Convulsion—Vandetanib—thyroid cancer	0.000461	0.0131	CcSEcCtD
Acetylsalicylic acid—Hypertension—Vandetanib—thyroid cancer	0.000459	0.013	CcSEcCtD
Acetylsalicylic acid—Eruption—Doxorubicin—thyroid cancer	0.000456	0.013	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Vandetanib—thyroid cancer	0.000453	0.0129	CcSEcCtD
Acetylsalicylic acid—Chest pain—Vandetanib—thyroid cancer	0.000453	0.0129	CcSEcCtD
Acetylsalicylic acid—PTGS1—trachea—thyroid cancer	0.000445	0.00638	CbGeAlD
Acetylsalicylic acid—Haematemesis—Epirubicin—thyroid cancer	0.000437	0.0124	CcSEcCtD
Acetylsalicylic acid—PTGS2—trachea—thyroid cancer	0.000426	0.0061	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Vandetanib—thyroid cancer	0.000425	0.0121	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Sorafenib—thyroid cancer	0.000414	0.0118	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Sorafenib—thyroid cancer	0.000412	0.0117	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Doxorubicin—thyroid cancer	0.000404	0.0115	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—thyroid cancer	0.000402	0.151	CrCbGaD
Acetylsalicylic acid—Dyspnoea—Vandetanib—thyroid cancer	0.000387	0.011	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Sorafenib—thyroid cancer	0.000384	0.0109	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—thyroid cancer	0.000384	0.0055	CbGeAlD
Acetylsalicylic acid—Flushing—Sorafenib—thyroid cancer	0.000383	0.0109	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Vandetanib—thyroid cancer	0.000382	0.0109	CcSEcCtD
Acetylsalicylic acid—PTGS1—thyroid gland—thyroid cancer	0.000352	0.00505	CbGeAlD
Acetylsalicylic acid—Anaemia—Sorafenib—thyroid cancer	0.000332	0.00942	CcSEcCtD
Acetylsalicylic acid—Angioedema—Sorafenib—thyroid cancer	0.000328	0.00931	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—thyroid cancer	0.000322	0.121	CrCbGaD
Acetylsalicylic acid—Syncope—Sorafenib—thyroid cancer	0.000322	0.00914	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Sorafenib—thyroid cancer	0.000321	0.00912	CcSEcCtD
Acetylsalicylic acid—Ulcer—Epirubicin—thyroid cancer	0.000321	0.00911	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Sorafenib—thyroid cancer	0.000315	0.00896	CcSEcCtD
Acetylsalicylic acid—PTGS1—head—thyroid cancer	0.000313	0.00448	CbGeAlD
Acetylsalicylic acid—Hypertension—Sorafenib—thyroid cancer	0.00031	0.0088	CcSEcCtD
Acetylsalicylic acid—Pruritus—Vandetanib—thyroid cancer	0.000307	0.00873	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Sorafenib—thyroid cancer	0.000306	0.00868	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Epirubicin—thyroid cancer	0.000303	0.00862	CcSEcCtD
Acetylsalicylic acid—PTGS2—head—thyroid cancer	0.000299	0.00428	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Vandetanib—thyroid cancer	0.000297	0.00844	CcSEcCtD
Acetylsalicylic acid—Ulcer—Doxorubicin—thyroid cancer	0.000297	0.00843	CcSEcCtD
Acetylsalicylic acid—Melaena—Epirubicin—thyroid cancer	0.000296	0.00842	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Sorafenib—thyroid cancer	0.000293	0.00832	CcSEcCtD
Acetylsalicylic acid—Shock—Sorafenib—thyroid cancer	0.000288	0.00819	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vandetanib—thyroid cancer	0.000287	0.00816	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Sorafenib—thyroid cancer	0.000287	0.00815	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000281	0.00797	CcSEcCtD
Acetylsalicylic acid—Coma—Epirubicin—thyroid cancer	0.000277	0.00787	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vandetanib—thyroid cancer	0.000276	0.00784	CcSEcCtD
Acetylsalicylic acid—Melaena—Doxorubicin—thyroid cancer	0.000274	0.00779	CcSEcCtD
Acetylsalicylic acid—Rash—Vandetanib—thyroid cancer	0.000274	0.00778	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vandetanib—thyroid cancer	0.000274	0.00777	CcSEcCtD
Acetylsalicylic acid—ABCB1—trachea—thyroid cancer	0.000263	0.00377	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Sorafenib—thyroid cancer	0.000261	0.00742	CcSEcCtD
Acetylsalicylic acid—Nausea—Vandetanib—thyroid cancer	0.000258	0.00733	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Sorafenib—thyroid cancer	0.000258	0.00732	CcSEcCtD
Acetylsalicylic acid—Coma—Doxorubicin—thyroid cancer	0.000257	0.00729	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Epirubicin—thyroid cancer	0.000253	0.00719	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Epirubicin—thyroid cancer	0.000246	0.00699	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000234	0.00665	CcSEcCtD
Acetylsalicylic acid—Urticaria—Sorafenib—thyroid cancer	0.000233	0.00661	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Epirubicin—thyroid cancer	0.000231	0.00657	CcSEcCtD
Acetylsalicylic acid—Purpura—Epirubicin—thyroid cancer	0.000228	0.00649	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Doxorubicin—thyroid cancer	0.000228	0.00647	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Epirubicin—thyroid cancer	0.000226	0.00641	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00022	0.00626	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—thyroid cancer	0.000219	0.00314	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Sorafenib—thyroid cancer	0.000216	0.00613	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Doxorubicin—thyroid cancer	0.000214	0.00608	CcSEcCtD
Acetylsalicylic acid—Purpura—Doxorubicin—thyroid cancer	0.000211	0.00601	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—thyroid cancer	0.000209	0.003	CbGeAlD
Acetylsalicylic acid—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000209	0.00593	CcSEcCtD
Acetylsalicylic acid—ABCB1—thyroid gland—thyroid cancer	0.000208	0.00299	CbGeAlD
Acetylsalicylic acid—Pruritus—Sorafenib—thyroid cancer	0.000207	0.00589	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000204	0.00579	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Epirubicin—thyroid cancer	0.0002	0.00569	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Sorafenib—thyroid cancer	0.0002	0.00569	CcSEcCtD
Acetylsalicylic acid—Dizziness—Sorafenib—thyroid cancer	0.000194	0.0055	CcSEcCtD
Acetylsalicylic acid—Asthma—Epirubicin—thyroid cancer	0.00019	0.00541	CcSEcCtD
Acetylsalicylic acid—Influenza—Epirubicin—thyroid cancer	0.00019	0.00541	CcSEcCtD
Acetylsalicylic acid—Vomiting—Sorafenib—thyroid cancer	0.000186	0.00529	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Doxorubicin—thyroid cancer	0.000185	0.00527	CcSEcCtD
Acetylsalicylic acid—ABCB1—head—thyroid cancer	0.000185	0.00265	CbGeAlD
Acetylsalicylic acid—Rash—Sorafenib—thyroid cancer	0.000185	0.00525	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Sorafenib—thyroid cancer	0.000185	0.00524	CcSEcCtD
Acetylsalicylic acid—Influenza—Doxorubicin—thyroid cancer	0.000176	0.005	CcSEcCtD
Acetylsalicylic acid—Asthma—Doxorubicin—thyroid cancer	0.000176	0.005	CcSEcCtD
Acetylsalicylic acid—Nausea—Sorafenib—thyroid cancer	0.000174	0.00494	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—thyroid cancer	0.00017	0.00482	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—thyroid cancer	0.000163	0.00462	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—thyroid cancer	0.000157	0.00446	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—thyroid cancer	0.000153	0.00435	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—thyroid cancer	0.000152	0.00433	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—thyroid cancer	0.000151	0.00428	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—thyroid cancer	0.000142	0.00404	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—thyroid cancer	0.000142	0.00402	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—thyroid cancer	0.000141	0.00402	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—thyroid cancer	0.000141	0.004	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—thyroid cancer	0.000131	0.00373	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—thyroid cancer	0.000131	0.00372	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—thyroid cancer	0.000129	0.00185	CbGeAlD
Acetylsalicylic acid—Anaemia—Epirubicin—thyroid cancer	0.000123	0.00348	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—thyroid cancer	0.000122	0.00346	CcSEcCtD
Acetylsalicylic acid—Vertigo—Epirubicin—thyroid cancer	0.000119	0.00338	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—thyroid cancer	0.000119	0.00338	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—thyroid cancer	0.000119	0.00337	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—thyroid cancer	0.000117	0.00331	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—thyroid cancer	0.000115	0.00326	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—thyroid cancer	0.000115	0.00325	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—thyroid cancer	0.000113	0.00322	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—thyroid cancer	0.000113	0.00321	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—thyroid cancer	0.000113	0.00321	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—thyroid cancer	0.000113	0.0032	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—thyroid cancer	0.00011	0.00313	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—thyroid cancer	0.00011	0.00313	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—thyroid cancer	0.00011	0.00312	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—thyroid cancer	0.000109	0.0031	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—thyroid cancer	0.000108	0.00307	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—thyroid cancer	0.000108	0.00306	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—thyroid cancer	0.000106	0.00302	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—thyroid cancer	0.000106	0.00302	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.000106	0.00301	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—thyroid cancer	0.000106	0.00301	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—thyroid cancer	0.000106	0.003	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—thyroid cancer	0.000105	0.00297	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—thyroid cancer	0.000104	0.00297	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—thyroid cancer	0.000104	0.00297	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—thyroid cancer	0.000101	0.00287	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0001	0.00284	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—thyroid cancer	9.85e-05	0.0028	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—thyroid cancer	9.81e-05	0.00279	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—thyroid cancer	9.77e-05	0.00278	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—thyroid cancer	9.68e-05	0.00275	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—thyroid cancer	9.65e-05	0.00274	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—thyroid cancer	9.62e-05	0.00273	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—thyroid cancer	9.53e-05	0.00271	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—thyroid cancer	8.93e-05	0.00254	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—thyroid cancer	8.92e-05	0.00253	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—thyroid cancer	8.9e-05	0.00253	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—thyroid cancer	8.82e-05	0.0025	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—thyroid cancer	8.6e-05	0.00244	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—thyroid cancer	8.25e-05	0.00234	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—thyroid cancer	7.97e-05	0.00227	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—thyroid cancer	7.96e-05	0.00226	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—thyroid cancer	7.66e-05	0.00218	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—thyroid cancer	7.41e-05	0.0021	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—thyroid cancer	7.38e-05	0.0021	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—thyroid cancer	7.16e-05	0.00203	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—thyroid cancer	7.09e-05	0.00201	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—thyroid cancer	6.88e-05	0.00195	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—thyroid cancer	6.85e-05	0.00195	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—thyroid cancer	6.82e-05	0.00194	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—thyroid cancer	6.82e-05	0.00194	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—thyroid cancer	6.62e-05	0.00188	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—thyroid cancer	6.43e-05	0.00183	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—thyroid cancer	6.37e-05	0.00181	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—thyroid cancer	6.31e-05	0.00179	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—thyroid cancer	6.31e-05	0.00179	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—thyroid cancer	5.95e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—AKT1—thyroid cancer	2.21e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CHST14—thyroid cancer	2.21e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KRAS—thyroid cancer	2.21e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HPGD—thyroid cancer	2.19e-05	0.000178	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.18e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HPGD—thyroid cancer	2.17e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TERT—thyroid cancer	2.17e-05	0.000176	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.16e-05	0.000176	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRG1—thyroid cancer	2.16e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRG1—thyroid cancer	2.16e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTEN—thyroid cancer	2.16e-05	0.000175	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—BRAF—thyroid cancer	2.15e-05	0.000174	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TERT—thyroid cancer	2.15e-05	0.000174	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—thyroid cancer	2.13e-05	0.000173	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—thyroid cancer	2.12e-05	0.000173	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	2.12e-05	0.000172	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—thyroid cancer	2.1e-05	0.00017	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HIF1A—thyroid cancer	2.08e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—thyroid cancer	2.07e-05	0.000168	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDK1—thyroid cancer	2.07e-05	0.000168	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HIF1A—thyroid cancer	2.05e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—AKT1—thyroid cancer	2.03e-05	0.000165	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—thyroid cancer	2.02e-05	0.000164	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IFNA2—thyroid cancer	2.01e-05	0.000163	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNA2—thyroid cancer	1.99e-05	0.000162	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TSHR—thyroid cancer	1.98e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—AKT1—thyroid cancer	1.96e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—KRAS—thyroid cancer	1.96e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HPGD—thyroid cancer	1.95e-05	0.000159	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TPR—thyroid cancer	1.94e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRKAR1A—thyroid cancer	1.94e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TERT—thyroid cancer	1.94e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TERT—thyroid cancer	1.94e-05	0.000158	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—thyroid cancer	1.93e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KRAS—thyroid cancer	1.92e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PRKAR1A—thyroid cancer	1.91e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HPGD—thyroid cancer	1.91e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—AKT1—thyroid cancer	1.88e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—thyroid cancer	1.88e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—AKT1—thyroid cancer	1.88e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—PTEN—thyroid cancer	1.87e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MEN1—thyroid cancer	1.86e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HIF1A—thyroid cancer	1.86e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HIF1A—thyroid cancer	1.86e-05	0.000151	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—AKT1—thyroid cancer	1.85e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TPR—thyroid cancer	1.84e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.84e-05	0.000149	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRKAR1A—thyroid cancer	1.81e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTEN—thyroid cancer	1.81e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HPGD—thyroid cancer	1.78e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—AKT1—thyroid cancer	1.78e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.77e-05	0.000144	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.76e-05	0.000143	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.75e-05	0.000142	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.74e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.73e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MEN1—thyroid cancer	1.73e-05	0.000141	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—BRAF—thyroid cancer	1.72e-05	0.00014	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—BRAF—thyroid cancer	1.7e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTCH1—thyroid cancer	1.68e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.68e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—PTEN—thyroid cancer	1.67e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—thyroid cancer	1.67e-05	0.000136	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—thyroid cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRG1—thyroid cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—KRAS—thyroid cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—AKT1—thyroid cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—thyroid cancer	1.64e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—thyroid cancer	1.64e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—thyroid cancer	1.64e-05	0.000133	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.6e-05	0.00013	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.58e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCND1—thyroid cancer	1.57e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TPR—thyroid cancer	1.54e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.54e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—BRAF—thyroid cancer	1.54e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SST—thyroid cancer	1.54e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—BRAF—thyroid cancer	1.54e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.52e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PTEN—thyroid cancer	1.51e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—thyroid cancer	1.49e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CALCA—thyroid cancer	1.48e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.47e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—SLC5A5—thyroid cancer	1.46e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—AKT1—thyroid cancer	1.44e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.44e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KRAS—thyroid cancer	1.44e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—PTEN—thyroid cancer	1.43e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—thyroid cancer	1.41e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—thyroid cancer	1.41e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—thyroid cancer	1.41e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CALCA—thyroid cancer	1.38e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.38e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PTEN—thyroid cancer	1.37e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.36e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—thyroid cancer	1.35e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDK1—thyroid cancer	1.34e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.3e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—thyroid cancer	1.29e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—thyroid cancer	1.28e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TPR—thyroid cancer	1.26e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCND1—thyroid cancer	1.25e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDK1—thyroid cancer	1.25e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TPR—thyroid cancer	1.25e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—thyroid cancer	1.24e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCND1—thyroid cancer	1.24e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.23e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	9.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—thyroid cancer	1.22e-05	9.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—RXRA—thyroid cancer	1.22e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—thyroid cancer	1.22e-05	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTEN—thyroid cancer	1.21e-05	9.83e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTEN—thyroid cancer	1.2e-05	9.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—thyroid cancer	1.2e-05	9.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—thyroid cancer	1.2e-05	9.71e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.19e-05	9.66e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—thyroid cancer	1.16e-05	9.44e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—thyroid cancer	1.16e-05	9.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.16e-05	9.38e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	9.11e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	9.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TPR—thyroid cancer	1.12e-05	9.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	9.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.11e-05	9.04e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.1e-05	8.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—thyroid cancer	1.1e-05	8.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TPR—thyroid cancer	1.09e-05	8.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.09e-05	8.88e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—thyroid cancer	1.09e-05	8.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	8.79e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	8.79e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—thyroid cancer	1.08e-05	8.77e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—thyroid cancer	1.08e-05	8.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.08e-05	8.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRG1—thyroid cancer	1.07e-05	8.73e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—thyroid cancer	1.07e-05	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	8.58e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	8.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—thyroid cancer	1.05e-05	8.56e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—thyroid cancer	1.04e-05	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—thyroid cancer	1.03e-05	8.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TPR—thyroid cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.01e-05	8.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRG1—thyroid cancer	1e-05	8.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1e-05	8.12e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—thyroid cancer	9.87e-06	8.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RXRA—thyroid cancer	9.71e-06	7.88e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—thyroid cancer	9.66e-06	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—thyroid cancer	9.66e-06	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—thyroid cancer	9.65e-06	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—thyroid cancer	9.65e-06	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.44e-06	7.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SLC5A5—thyroid cancer	9.4e-06	7.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	9.38e-06	7.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SLC5A5—thyroid cancer	9.35e-06	7.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—thyroid cancer	9.33e-06	7.58e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—thyroid cancer	9.3e-06	7.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.24e-06	7.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HIF1A—thyroid cancer	9.23e-06	7.49e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—thyroid cancer	9.19e-06	7.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.12e-06	7.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—thyroid cancer	9e-06	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—thyroid cancer	8.96e-06	7.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.81e-06	7.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.76e-06	7.11e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—thyroid cancer	8.72e-06	7.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HIF1A—thyroid cancer	8.61e-06	6.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SLC5A5—thyroid cancer	8.39e-06	6.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—thyroid cancer	8.33e-06	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—thyroid cancer	8.31e-06	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—thyroid cancer	8.31e-06	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—thyroid cancer	8.27e-06	6.71e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—thyroid cancer	8.24e-06	6.69e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.19e-06	6.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—thyroid cancer	7.91e-06	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—thyroid cancer	7.9e-06	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RXRA—thyroid cancer	7.9e-06	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.87e-06	6.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RXRA—thyroid cancer	7.86e-06	6.38e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—thyroid cancer	7.81e-06	6.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—thyroid cancer	7.72e-06	6.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.69e-06	6.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SLC5A5—thyroid cancer	7.65e-06	6.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—thyroid cancer	7.64e-06	6.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.64e-06	6.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—thyroid cancer	7.49e-06	6.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—thyroid cancer	7.43e-06	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—thyroid cancer	7.39e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—thyroid cancer	7.39e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.17e-06	5.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—thyroid cancer	7.13e-06	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—thyroid cancer	7.07e-06	5.74e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—thyroid cancer	7.07e-06	5.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RXRA—thyroid cancer	7.05e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—thyroid cancer	6.98e-06	5.67e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—thyroid cancer	6.9e-06	5.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RXRA—thyroid cancer	6.88e-06	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.86e-06	5.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—thyroid cancer	6.45e-06	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RXRA—thyroid cancer	6.43e-06	5.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—thyroid cancer	6.39e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.25e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—thyroid cancer	6.24e-06	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—thyroid cancer	6.24e-06	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—thyroid cancer	6.13e-06	4.98e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—thyroid cancer	6.08e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—thyroid cancer	5.73e-06	4.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—thyroid cancer	5.58e-06	4.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—thyroid cancer	5.48e-06	4.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—thyroid cancer	5.44e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—thyroid cancer	5.38e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—thyroid cancer	5.3e-06	4.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—thyroid cancer	5.02e-06	4.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—thyroid cancer	4.99e-06	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—thyroid cancer	4.96e-06	4.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—thyroid cancer	4.84e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—thyroid cancer	4.8e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—thyroid cancer	4.8e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—thyroid cancer	4.48e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—thyroid cancer	4.45e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—thyroid cancer	4.35e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—thyroid cancer	4.21e-06	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—thyroid cancer	4.13e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—thyroid cancer	4.06e-06	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.92e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—thyroid cancer	3.9e-06	3.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—thyroid cancer	3.86e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—thyroid cancer	3.67e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—thyroid cancer	3.51e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.5e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—thyroid cancer	3.42e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—thyroid cancer	3.42e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—thyroid cancer	3.4e-06	2.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—thyroid cancer	3.28e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.19e-06	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—thyroid cancer	3.1e-06	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—thyroid cancer	3.05e-06	2.48e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—thyroid cancer	3.05e-06	2.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—thyroid cancer	2.98e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—thyroid cancer	2.89e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—thyroid cancer	2.79e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—thyroid cancer	2.42e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—thyroid cancer	1.97e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—thyroid cancer	1.96e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—thyroid cancer	1.76e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—thyroid cancer	1.72e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—thyroid cancer	1.61e-06	1.3e-05	CbGpPWpGaD
